COMMUNIQUÉS West-GlobeNewswire

Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights

08/05/2024 - 14:00

Data from long-term extension of Phase 2 VISIONARY-MS clinical trial of CNM-Au8 ® demonstrated significant evidence of repair and remyelination across multiple paraclinical endpoints (change from original baseline, p [...]

Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

08/05/2024 - 14:00

SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases [...]

Recce Pharmaceuticals Granted New Patent in China for RECCE® Anti-Infectives

08/05/2024 - 14:00

SYDNEY, Australia, May 08, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd. (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, today announced the China National Intellectual [...]

Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research

08/05/2024 - 14:00

Expanded Activities Position Rakovina Therapeutics to Capitalize on AI Partnerships with The University of British Columbia and Pharma Inventor Inc. VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Rakovina [...]

Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024

08/05/2024 - 14:00

CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare [...]

BioAtla to Participate in the Citizens JMP Life Sciences Conference

08/05/2024 - 14:00

SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the [...]

Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results

08/05/2024 - 14:00

LEXINGTON, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]

Fulcrum Therapeutics Announces Publication of Results from Phase 2b Clinical Trial of Losmapimod in Facioscapulohumeral muscular dystrophy (ReDUX4) in The Lancet Neurology

08/05/2024 - 14:00

― Phase 2b ReDUX4 clinical trial indicates improvements in functional, structural, and patient-reported outcomes; findings informed the design and choice of efficacy endpoints in the ongoing Phase 3 clinical trial― ― [...]

ONCOTELIC PRESENTING AT BIOPHARMA NEXUS CONFERENCE SAN DIEGO 2024

08/05/2024 - 14:00

AGOURA HILLS, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its presentation at Biopharma Nexus Conference. Dr. Andy Hu, Nanomedicine Manager, will be presenting: [...]

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

08/05/2024 - 14:00

NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) [...]

TytoCare and Urgent Care Association to Host Major Health System Leaders for Rural & Urgent Care Clinic Virtual Summit

08/05/2024 - 14:00

Leaders from Corewell Health, Avel eCare, Sanford Health, Urgent Care Association, and others will share how their remote care initiatives are improving healthcare access NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- [...]

ArriVent BioPharma Reports First Quarter 2024 Financial Results

08/05/2024 - 14:00

Presented preclinical firmonertinib (formerly furmonertinib) data at the 2024 American Association for Cancer Research (“AACR”) Annual Meeting Dosed first patient in Phase 1b combination study of firmonertinib and ICP- [...]

Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events

08/05/2024 - 14:00

BASKING RIDGE, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of [...]

IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO

08/05/2024 - 14:00

Assumes leadership role as Company anticipates multiple near-term clinical milestones Brings extensive leadership and experience in drug development and business strategy LAWRENCEVILLE, N.J., May 08, 2024 (GLOBE [...]

ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases

08/05/2024 - 14:00

ProQR scientists report for the first time in the ADAR RNA editing field in vivo proof of target engagement (RNA editing) leading to meaningful changes in biomarkers in NHPs using Axiomer™ RNA Editing Oligonucleotides [...]

60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial of Tafenoquine in Babesiosis in Letter to Journal of Infectious Diseases

08/05/2024 - 13:59

The U.S. medical scientific community is calling for clinical studies to expand shared understanding of babesiosis, an emerging tick-borne illness. The upcoming 60 Degrees Pharma clinical trial of tafenoquine in [...]

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

08/05/2024 - 13:55

Total Revenue Increased 25% to $51.3 Million Record First Quarter MACI Revenue of $40.2 Million and Burn Care Revenue Growth of 63% Adjusted EBITDA Growth of 325% Full-Year 2024 Revenue Guidance Raised to $238-$242 [...]

Treos Bio to Present New Clinical Data on Off-the-Shelf Peptide Immunotherapy for Colorectal Cancer at 2024 ASCO Annual Meeting

08/05/2024 - 13:45

LONDON and BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Treos Bio, a clinical stage biotechnology company using data science and proprietary biomarkers to develop precision peptide immunotherapies, said investigators will [...]

IntelGenx Announces Voting Results on Election of Directors

08/05/2024 - 13:45

SAINT LAURENT, Quebec, May 08, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) (the “ Company ” or “ IntelGenx ”) announces that, at the annual meeting of shareholders of the Company held [...]